(Q24241429)

2

0 references

Robert Boyle

object named as

Robert John Boyle

1

0 references

Mimi Tang

5

object named as

Mimi LK Tang

0 references

author name string

Dedee F Murrell

Cochrane Database of Systematic Reviews

4

0 references

publication date

8 October 2008

0 references

published in

0 references

cites work

No effects of probiotics on atopic dermatitis in infancy: a randomized placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

Prospective, randomized controlled trial on Lactobacillus rhamnosus in infants with moderate to severe atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

Randomized, placebo-controlled trial of Lactobacillus rhamnosus GG as treatment of atopic dermatitis in infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

Probiotics in the management of atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

Probiotic bacteria in the management of atopic disease: underscoring the importance of viability

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

Probiotics: a novel approach in the management of food allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

Is the effect of probiotics on atopic dermatitis confined to food sensitized children?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

Effects of probiotics on atopic dermatitis: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

Rectal bleeding in infancy: clinical, allergological, and microbiological examination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

Evaluation of diet and growth in children with and without atopic eczema: follow-up study from birth to 4 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

Lactobacillus GG effect in increasing IFN-gamma production in infants with cow's milk allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

Effect of probiotics on gastrointestinal symptoms and small intestinal permeability in children with atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

Induction of inflammation as a possible mechanism of probiotic effect in atopic eczema-dermatitis syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

Probiotics for treating infectious diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

Delay of growth and development in children with bronchial asthma, atopic dermatitis and allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

Allergen sensitization through the skin induces systemic allergic responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

Allergy development and the intestinal microflora during the first year of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

Safety of probiotics that contain lactobacilli or bifidobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

Safety assessment of the oral cavity probiotic Streptococcus salivarius K12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

Gastrointestinal symptoms in atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

Outcome measures of disease severity in atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

Saccharomyces cerevisiae fungemia in an elderly patient with Clostridium difficile colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

Safety of D(-)-lactic acid producing bacteria in the human infant

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

Genetics and genomics of asthma and allergic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

Cost of atopic dermatitis and eczema in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

Severity distribution of atopic dermatitis in the community and its relationship to secondary referral

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

Complementary/alternative medicine in dermatology: evidence-assessed efficacy of two diseases and two treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

The epidemiology and experience of atopic eczema during childhood: a discussion paper on the implications of current knowledge for health care, public health policy and research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

How atopic is atopic dermatitis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

Possible role of catheters in Saccharomyces boulardii fungemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

Systematic reviews in health care: Assessing the quality of controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

Atopic eczema: its social and financial costs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

Pharmacoeconomics of drug therapy for atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

Lactobacillus sepsis associated with probiotic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

In vivo safety assessment of two Bifidobacterium longum strains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

Management of atopic eczema. Joint Workshop of the British Association of Dermatologists and the Research Unit of the Royal College of Physicians of London

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

Fecal microbiota in sensitized wheezy and non-sensitized non-wheezy children: a nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

Probiotics in infants for prevention of allergic disease and food hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

The interaction between particulate air pollution and allergens in enhancing allergic and airway responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

Skin lipids and epidermal differentiation in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

Demonstration of safety of probiotics -- a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

The effect of consumption of milk fermented by Lactobacillus casei strain Shirota on the intestinal microflora and immune parameters in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

Clinical safety of Lactobacillus casei shirota as a probiotic in critically ill children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

Atopic eczema: its impact on the family and financial cost

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

Treatment principles of atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

21 January 2018

Early events in atopy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

Clinical practice. Atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

Safety and tolerance of Lactobacillus reuteri supplementation to a population infected with the human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

7 January 2021

The family impact of childhood atopic dermatitis: the Dermatitis Family Impact questionnaire

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

7 January 2021

Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

7 January 2021

Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

7 January 2021

Effect of probiotic Lactobacillus strains in children with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

7 January 2021

Clinical features of atopic dermatitis at two years of age: a prospective, population-based case-control study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

7 January 2021

Probiotics and safety

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

7 January 2021

Probiotic use in clinical practice: what are the risks?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

7 January 2021

Saccharomyces cerevisiae fungemia after Saccharomyces boulardii treatment in immunocompromised patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

7 January 2021

Role of food allergy in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

7 January 2021

Lactobacillus rhamnosus GG bacteremia associated with probiotic use in a child with short gut syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

7 January 2021

Clinical effects of probiotics are associated with increased interferon-gamma responses in very young children with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

7 January 2021

LKM512 yogurt consumption improves the intestinal environment and induces the T-helper type 1 cytokine in adult patients with intractable atopic dermatitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

7 January 2021

Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

7 January 2021

Prebiotics and synbiotics: two promising approaches for the treatment of atopic dermatitis in children above 2 years

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

7 January 2021

A randomized, single-blind and crossover study of an amino acid-based milk formula in treating young children with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

7 January 2021

Probiotic effects on faecal inflammatory markers and on faecal IgA in food allergic atopic eczema/dermatitis syndrome infants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

7 January 2021

A new synbiotic, Lactobacillus casei subsp. casei together with dextran, reduces murine and human allergic reaction

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

7 January 2021

Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006135.PUB2

7 January 2021

10.1002/14651858.CD006135.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

4213875

4213875

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference